NRSN

Neurosense Therapeutics Ltd

1.680

+0.285+20.43%

After Hours: 1.600 -0.080 -4.76%19:08 11/06 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE1.470/1.395

TODAY RANGE1.300-1.680

VOL17.31K

MARKET CAP3.19M

52 WEEK RANGE1.100-25.40

AVG VOL (3M)30.46K

% TURNOVER0.81%

TURNOVER--

P/E (TTM)-0.8163

% RANGE27.23%

EPS(TTM)-2.0580

P/E(FORWARD)-0.3327

P/B-1.4669

BVPS-1.1453

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.19M

SHARES OUTSTANDING1.90M

NEXT EARNINGS--

FREE FLOAT1.30M

LOT SIZE1

EX-DATE09/14/2026

News

Press Releases

Financial Reports

Profile

Dow Jones·4d ago
NeuroSense Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
TipRanks·4d ago
NeuroSense downgraded to Neutral from Buy at H.C. Wainwright
TipRanks·4d ago
NeuroSense downgraded at H.C. Wainwright on extended PrimeC timelines
TipRanks·4d ago
NeuroSense adds new data to its Canadian submission of ALS candidate
PR Newswire·10/29 15:30
NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC's Phase 3 Development at NEALS 2026
TipRanks·10/26 17:17
NeuroSense Therapeutics Moves to Early PrimeC Commercialization in U.S.
NASDAQ·10/26 16:58
NeuroSense Therapeutics Ltd. Targets Revenues in 2027 Under Strategic Collaboration Agreement
TipRanks·10/19 14:23
NeuroSense Files U.S. Patent to Extend PrimeC into Traumatic Brain Injury
TipRanks·10/19 12:37
NeuroSense files patent in USPTO covering methods to treat TBI
NASDAQ·10/14 09:17
NeuroSense Appeals Nasdaq Delisting Determination, Hearing Date Set For Nov. 10
TipRanks·10/13 12:57
NeuroSense Wins Nasdaq Hearing Date as PrimeC Nears Key Regulatory and Funding Milestones
TipRanks·10/13 12:42
NeuroSense secures Nasdaq hearing date as PrimeC approaches milestones
TipRanks·10/12 20:35
NeuroSense downgraded to Neutral from Buy at Roth Capital
TipRanks·10/02 20:47
NeuroSense Regains Nasdaq Bid Price Compliance, Appeals Market Value Delisting Notice
NASDAQ·10/02 11:10
NeuroSense Therapeutics Consensus Price Target Increased by 1,507.27% to $112.71

Same Industry

Name/Symbol

Change%

Price

NRSN

REGN

GRDX

BNTX

UTHR

SIGA

VRTX

Moderna

MRNA

+5.27%

254.19

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLN

GILD

ARCT

PRAH

APVO

INCY

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.